Nu Holdings is delivering 40% FXN revenue growth but trades at a substantial discount to its growth profile. The fintech's profitability is exceptional, with a 33% ROE, 17.3% NIM, and an efficiency ...
On CNBC's “Halftime Report Final Trades,” Kevin Simpson, Capital Wealth Planning founder and CIO, named Nu Holdings Ltd (NYSE: NU) as his final trade. Lending support to his choice, Nu Holdings, on ...
Nu Holdings remains a Strong Buy with a $19 price target, implying 14% upside and market outperformance. Q3 2025 results delivered 42% revenue growth and 45% EPS growth, both exceeding analyst ...
In recent weeks, analysts have become more optimistic on Nu Holdings, with Grupo Santander upgrading the stock and broader earnings estimates for upcoming quarters and fiscal years moving higher. At ...
Hosted on MSN
Should you buy Nu Holdings while it's below $20?
Nu has achieved tremendous success by leveraging technology to capture the banking opportunity in Latin America. The company’s incredible unit economics support its profitability, as net income ...
Sally Pipes is the Pacific Research Institute’s president, CEO and Thomas W. Smith Fellow in Health Care policy who analyzes the latest health care trends and topics including single-payer, Obamacare, ...
The race to the championship starts with the UAAP Season 88 men’s basketball Final Four, which opens on Wednesday, December 3. NU and UP hold a twice-to-beat advantage over La Salle and UST, ...
Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback